Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 58.05
-0.51 (-0.87%)
Apr 30, 2026, 10:44 AM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 6.40 billion as of April 29, 2026. Its market cap has increased by 25.05% in one year.
Market Cap
6.40B
Enterprise Value
6.60B
Revenue
1.19B
Ranking
n/a
PE Ratio
33.31
Stock Price
58.05
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 6.40B, a decrease of -33.39%. That is a compound annual growth rate of -8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 6.40B | -5.78% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hunan Jiudian Pharmaceutical | 6.34B |
| Tibet Duo Rui Pharmaceutical | 6.37B |
| Heilongjiang ZBD Pharmaceutical | 6.23B |
| ChengDa Pharmaceuticals | 6.10B |
| Jinghua Pharmaceutical Group | 6.05B |
| Shandong Wit Dyne Health | 6.64B |
| Guizhou Xinbang Pharmaceutical | 6.01B |
| Hainan Haiyao | 6.67B |